Related Experiment Video
Updated: Jan 19, 2026

12:03
Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
5.0K
Fertility Preservation in Women With Malignancy: Future Endeavors
1Reproductive Endocrinology, Ob/Gyn, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Clinical Medicine Insights. Reproductive Health
|September 25, 2019
Summary
Fertility preservation is advancing, with embryo and oocyte cryopreservation as established methods. Future innovations like in vitro maturation and artificial ovaries may offer safer alternatives, bypassing risks associated with ovarian tissue transplantation.
Area of Science:
- Reproductive medicine
- Oncofertility
- Cryobiology
Background:
- Fertility preservation is a rapidly evolving field.
- Established methods include embryo and oocyte cryopreservation.
- Other techniques like GnRH analogues and ovarian cryopreservation are discussed in related manuscripts.
Purpose of the Study:
- To summarize current and future options for fertility preservation.
- To highlight emerging technologies that may offer safer alternatives.
- To contextualize the established methods within the broader landscape of fertility preservation.
Main Methods:
- Review of existing literature and ongoing research in fertility preservation.
- Discussion of established techniques (embryo/oocyte cryopreservation).
- Exploration of potential future technologies (in vitro maturation, artificial ovary).
Main Results:
- Embryo and unfertilized oocyte cryopreservation are the only unequivocally accepted methods.
- GnRH analogues and ovarian cryopreservation have ongoing debates and are covered in detail elsewhere.
- Emerging technologies like in vitro maturation and artificial ovaries show promise for the future.
Conclusions:
- Future fertility preservation may involve in vitro maturation and artificial ovaries.
- These novel technologies could mitigate risks of malignancy recurrence associated with ovarian tissue transplantation.
- Continued research is essential for advancing safe and effective fertility preservation strategies.
Related Concept Videos
Infertility in Females
3.7K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.7K
Infertility in Males
528
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
528
Oogenesis
69.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
69.1K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

